Details:

Alternative Title:
Anal Chem
Publisher's site:
http://dx.doi.org/10.1021/ac4015885
Personal Author:
Wang, Yanru ; Li, Peiwu ; Majkova, Zuzana ; Bever, Candace R. S. ; Kim, Hee Joo ; ... More +
Wang, Yanru ; Li, Peiwu ; Majkova, Zuzana ; Bever, Candace R. S. ; Kim, Hee Joo ; Zhang, Qi ; Dechant, Julie E. ; Gee, Shirley J. ; Hammock, Bruce D. ; Less -
Description:
Anti-idiotypic antibodies recognize the antigenic determinants of an antibody, thus they can be used as surrogate antigens. Single-domain antibodies from camlid heavy-chain antibodies with the benefit features of small size, thermostability, and ease in expression, are leading candidates to produce anti-idiotypic antibodies. In this work, we constructed an antibody phage library from the mRNA of an alpaca immunized with an antiaflatoxin monoclonal antibody (mAb) 1C11. Three anti-idiotypic VHH antibodies were isolated and applied to immunoassay toward aflatoxin as a coating antigen. The best immunoassay developed with one of these VHH antibodies shows an IC50 of 0.16 ng/mL toward aflatoxin B1 and cross-reactivity toward aflatoxin B2, G1, and G2 of 90.4%, 54.4%, and 37.7%, respectively. The VHH-based immunoassay was successfully applied to the analysis of peanuts, corn, and rice, which are the predominant commodities regularly contaminated by aflatoxins. A good correlation (r(2) = 0.89) was found between the data obtained from the conventional ELISA and the ELISA based on a VHH coating antigen for the analysis of aflatoxins in peanuts and feedstuff. The use of biotechnology in developing the surrogate, the absence of standard aflatoxin and organic solvents in the synthesis procedures, and the reproducibility of the VHH antibody makes it an ideal strategy for replacing conventional synthesized antigens.
Subject:
[+]
Aflatoxins
Animals
Antibodies, Anti-Idiotypic
Camelids, New World
Enzyme-Linked Immunosorbent Assay
Immunoassay
Male

Source:
Anal Chem. 85(17):8298-8303. ;
Pubmed ID:
23965250
Pubmed Central ID:
PMC3787825
Document Type:
Journal Article ;
Funding:
P42 ES004699/ES/NIEHS NIH HHS/United States ; P42 ES04699/ES/NIEHS NIH HHS/United States ; U50 OH07550/OH/NIOSH CDC HHS/United States ; U54 NS079202/NS/NINDS NIH HHS/United States ; U54NS079202/NS/NINDS NIH HHS/United States ;
P42 ES004699/ES/NIEHS NIH HHS/United States ; P42 ES04699/ES/NIEHS NIH HHS/United States ; U50 OH07550/OH/NIOSH CDC HHS/United States ; U54 NS079202/NS/NINDS NIH HHS/United States ; U54NS079202/NS/NINDS NIH HHS/United States ; Less -
Collection(s):
CDC Public Access
Main Document Checksum:
[+]
urn:sha256:35d310011210f32a5b63474f8732da62050e9d714909f00a3ca197c086ebeeb1
File Type:

Supporting Files

• 	nihms513187f4.gif	gif
  	nihms513187f4.jpg	jpeg
  	NIHMS513187-supplement-1_si_001.pdf	pdf
  	nihms513187.nxml	txt
  	nihms513187f1.gif	gif
  	nihms513187f1.jpg	jpeg
  	nihms513187f2.gif	gif
  	nihms513187f2.jpg	jpeg
  	nihms513187f3.gif	gif
  	nihms513187f3.jpg	jpeg

More +